|
Arteriovenous Anastomosis
|
D001163 |
[A vessel that directly interconnects an artery and a vein, and that acts as a shunt to bypass the CAPILLARY BEDS. Not to be confused with SURGICAL ANASTOMOSIS or ARTERIOVENOUS FISTULA.
] |
|
Arthritis
|
D001168 |
[Acute or chronic inflammation of JOINTS.
] |
|
HLA-DP Antigens
|
D12.776.543.550.440.400.420 |
|
|
Arthritis, Experimental
|
D001169 |
[ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN.
, An experimental model of arthritis that is induced by injecting COLLAGEN to stimulate the immune response.
, An experimental model of arthritis that is induced by injecting adjuvants. These adjuvants generally consists of a mixture of light paraffin oil, emulsifying agent, and infective agents or antigens, such as killed mycobacteria or bacterial lipopolysaccharides.
] |
|
Technetium Tc 99m Lidofenin
|
D02.691.825.710 |
|
|
Arteriovenous Shunt, Surgical
|
D001166 |
[Surgical shunt allowing direct passage of blood from an artery to a vein. (From Dorland, 28th ed)
] |
|
Arteritis
|
D001167 |
[INFLAMMATION of any ARTERIES.
] |
|
Phaeohyphomycosis
|
C01.150.703.726 |
|
|
von Willebrand Disease, Type 1
|
C15.378.463.920.100 |
|
|
von Willebrand Diseases
|
C15.378.463.920 |
|
|
Arthritis, Juvenile
|
D001171 |
[Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.
] |
|
Thiosulfate Sulfurtransferase
|
D08.811.913.817.500.500 |
|
|
Sulfurtransferases
|
D08.811.913.817.500 |
|
|
Arthritis, Rheumatoid
|
D001172 |
[A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
] |
|
Arthritis, Infectious
|
D001170 |
[Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES.
] |
|
Phosphodiesterase 3 Inhibitors
|
D27.505.519.389.735.249 |
|
|
Frasier Syndrome
|
C16.131.939.316.096.624 |
|
|
Osteolysis
|
G11.427.213.150.570 |
|
|
Bone Resorption
|
G11.427.213.150 |
|
|
Social Security
|
N03.219.521.576.823 |
|
